- Home
- JMSB vs AVTX Comparison
JMSB vs AVTX Comparison
Compare JMSB & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JMSB
- AVTX
- Stock Information
- Founded
- JMSB 2005
- AVTX 2011
- Country
- JMSB United States
- AVTX United States
- Employees
- JMSB N/A
- AVTX N/A
- Industry
- JMSB Major Banks
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- JMSB Finance
- AVTX Health Care
- Exchange
- JMSB Nasdaq
- AVTX Nasdaq
- Market Cap
- JMSB 276.5M
- AVTX 248.3M
- IPO Year
- JMSB N/A
- AVTX 2015
- Fundamental
- Price
- JMSB $19.17
- AVTX $18.38
- Analyst Decision
- JMSB Buy
- AVTX Strong Buy
- Analyst Count
- JMSB 2
- AVTX 9
- Target Price
- JMSB $22.50
- AVTX $30.14
- AVG Volume (30 Days)
- JMSB 15.2K
- AVTX 406.9K
- Earning Date
- JMSB 10-23-2025
- AVTX 11-07-2025
- Dividend Yield
- JMSB 1.56%
- AVTX N/A
- EPS Growth
- JMSB 688.28
- AVTX N/A
- EPS
- JMSB 1.32
- AVTX N/A
- Revenue
- JMSB $56,750,000.00
- AVTX $441,000.00
- Revenue This Year
- JMSB $18.55
- AVTX N/A
- Revenue Next Year
- JMSB $13.30
- AVTX N/A
- P/E Ratio
- JMSB $14.53
- AVTX N/A
- Revenue Growth
- JMSB 59.00
- AVTX N/A
- 52 Week Low
- JMSB $13.81
- AVTX $3.39
- 52 Week High
- JMSB $26.52
- AVTX $19.41
- Technical
- Relative Strength Index (RSI)
- JMSB 47.85
- AVTX 70.82
- Support Level
- JMSB $18.90
- AVTX $16.77
- Resistance Level
- JMSB $20.02
- AVTX $19.20
- Average True Range (ATR)
- JMSB 0.51
- AVTX 1.56
- MACD
- JMSB 0.03
- AVTX 0.25
- Stochastic Oscillator
- JMSB 39.72
- AVTX 83.52
About JMSB John Marshall Bancorp Inc.
John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).